MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

Common diabetes medications include metformin, sulfonylureas, and GLP-1 agonists, among others like DPP-4 inhibitors, TZDs, ...

SGLT2 inhibitor use may help stabilize eGFR levels for patients with autosomal dominant polycystic kidney disease and type 2 diabetes, according to study data.“Given its unique pathophysiology, ...

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile.